Awakn Life Sciences Corporation (QB) AWKNF Income Statements

	Real-time Prices	Level 2
Canadian Securities Exchange

*Across 3 years $738.72 only $295.49

Monitor
Quote
Level 2
Movers
Portfolio
Markets
Discussions
More

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.

AI Sign In

Premium

Support
1-888-992-3836
help@advfn.com

Year End January 30 2024	2022	2023	2024
	CAD ($)	CAD ($)	CAD ($)
Total Revenue	246k	1.5M	1.05M
Operating Income	-9.78M	-9.19M	-5.46M
Pre Tax Income	-16.47M	-9.65M	-5.1M
Net Income	-15.95M	-9.14M	-5.1M
Preferred Dividends	0	0	0
Basic Earnings Per Share (EPS)	-0.641	-0.282	-0.131
EBIT	-11.13M	-9.42M	-5.46M
EBITDA	-9.6M	-8.59M	-5.12M

Year End January 30 2024

2022

2023

2024

CAD ($)

Total Revenue

246k

1.5M

1.05M

Operating Income

-9.78M

-9.19M

-5.46M

Pre Tax Income

-16.47M

-9.65M

-5.1M

Net Income

-15.95M

-9.14M

-5.1M

Preferred Dividends

Basic Earnings Per Share (EPS)

-0.641

-0.282

-0.131

EBIT

-11.13M

-9.42M

-5.46M

EBITDA

-9.6M

-8.59M

-5.12M

*Across 3 years $1305.00 only $522.00

Market Data

News

Trading Tools

Markets

Discover